1-4 of 4
Ralph B. D’Agostino
Close
Sort by
Journal Articles

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Clinical Trials & Observations
Paul G. Richardson, Marcie L. Riches, Nancy A. Kernan, Joel A. Brochstein, Shin Mineishi, Amanda M. Termuhlen, Sally Arai, Stephan A. Grupp, Eva C. Guinan, Paul L. Martin, Gideon Steinbach, Amrita Krishnan, Eneida R. Nemecek, Sergio Giralt, Tulio Rodriguez, Reggie Duerst, John Doyle, Joseph H. Antin, Angela Smith, Leslie Lehmann, Richard Champlin, Alfred Gillio, Rajinder Bajwa, Ralph B. D’Agostino, Sr, Joseph Massaro, Diane Warren, Maja Miloslavsky, Robin L. Hume, Massimo Iacobelli, Bijan Nejadnik, Alison L. Hannah, Robert J. Soiffer
Journal: Blood
Blood (2016) 127 (13): 1656–1665.
https://doi.org/10.1182/blood-2015-10-676924
Published: 2016
Includes: Supplemental data
Journal Articles

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial

Paul G. Richardson, MD, Marcie Riches, MD, Nancy A. Kernan, MD, Joel A. Brochstein, MD, Shin Mineishi, MD, Amanda M. Termuhlen, MD, Sally Arai, MD, Stephan A. Grupp, MD PhD, Eva C. Guinan, MD, Paul L. Martin, MD PhD, Gideon Steinbach, MD PhD, Amrita Krishnan, Eneida R. Nemecek, MD, Sergio A. Giralt, MD, Tulio E. Rodriguez, MD, Reggie Duerst, MD, John J. Doyle, MD FRCPC, Joseph H. Antin, MD, Angela R. Smith, MD MS, Leslie E. Lehmann, MD, Richard E. Champlin, MD, Alfred Gillio, MD, Rajinder Bajwa, MBBS, MD MRCP, Ralph B. D'Agostino, PhD, Joseph Massaro, PhD, Maja Miloslavsky, PhD, Robin L. Hume, MS, Massimo Iacobelli, MD, Bijan Nejadnik, MD, Alison L. Hannah, MD, Robert J. Soiffer, MD
Journal: Blood
Blood (2015) 126 (23): 737.
https://doi.org/10.1182/blood.V126.23.737.737
Published: 2015
Journal Articles

Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol

Paul G. Richardson, MD, Angela R. Smith, MD, MS, Stephan A Grupp, MD, PhD, Nancy A. Kernan, MD, Sally Arai, MD, Paul R. Haut, MD, Brandon M. Triplett, MD, Alfred P. Gillio, III, MD, Heather J. Symons, Roberta H. Adams, MD, Biljana N. Horn, MD, Kenneth Lucas, MD, Paul L. Martin, MD, PhD, Shin Mineishi, MD, Edward D. Ball, M.D., Michael Boyer, MD, John Fort, MD, Ivan I. Kirov, MD, Leslie E. Lehmann, MD, Catherine Madigan, MD, Michelle E. Maglio, Joseph Massaro, Ph.D., Ralph B. D'Agostino, PhD, Alison L. Hannah, MD, Elena Tudone, Robin Hume, Massimo Iacobelli, MD, Robert J. Soiffer, MD, Defibrotide Study Group
Journal: Blood
Blood (2011) 118 (21): 487.
https://doi.org/10.1182/blood.V118.21.487.487
Published: 2011
Journal Articles

Association of γ’ Fibrinogen with Risk Factors and Prevalent Cardiovascular Disease in the Framingham Heart Study.

Rehana S. Lovely, PhD, Joseph F. Massaro, PhD, Ralph B. D’Agostino, Sr., PhD, Emelia J. Benjamin, PhD, Steven C. Kazmierczak, PhD, Christopher J. O’Donnell, MD, PhD, David H. Farrell, PhD
Journal: Blood
Blood (2007) 110 (11): 131.
https://doi.org/10.1182/blood.V110.11.131.131
Published: 2007